SHIJIAZHUANG PHARMACEUTICAL GROUP

OUYI PHARMA CO., LTD.

       Shijiazhuang Pharmaceutical Group Ouyi Pharma Co., Ltd.(hereafter referred as “Ouyi”)is one of the subsidiaries of Shijiazhuang Pharmaceutical Group Co., Ltd.(CSPC). Ouyi is a large-sizedsized comprehensive pharmaceutical enterprise engaged in scientific research, manufacture, and marketing of bulk pharmaceutical chemicals and finished dosage forms. The predecessor of Ouyi Pharma  Is Shijiazhuang No.1 Pharmaceutical Factory which was established in May,1938.Over more than 60 years' development, it has become a backbone pharmaceutical enterprise in China, mainly manufacturing formulations and synthetic bulk pharmaceutical chemicals. The annual industrial output amounts to RMB437.45 million with a taxable profit of about RMB54.69 million.

      Ouyi currently has 1762 employees including 301engineers and technicians, accounting for 17.1% of the staff and 120quality management personnel, accounting for 6.8%of the staff. The plant covers an area of 130,000m 2 , the construction area is about 86000m 2 , the green land area is about 5086 m 2 and the warehouse area is about 9000 m 2 .

     The product range of Ouyi covers semi-synthesized antibiotics, analgesic and anti-inflammatory products, cardiovascular series, anesthetic series, metabolic series, there are more than 20 kinds of pharmaceutical bulks and about 270 kinds of finished drugs　in form of tablets, capsules, granules, liquid　injections and powder for injections, suppositories, suspension　and oral liquid etc. Besides, Ouyi has already developed many new drugs in the past several years, such as Ouyi tablets (cefadroxil tabs), Weihong tablets (Azithromycin tabs), Kangweisu tabs (Vitamin BT tabs), Gubang tablets (sodium alendionate　tabs) , Pentoxyphylline sustained-release tablets, Acemetacin tablets, Epalaprili tablets and Tramadol Hcl tablets etc.

      We still have the pharmaceutical raw material ,e.g Tramadol Hydrochloride, Azithromycin, Indometacin and Cefadroxilum.

       To improve the manufacture facilities and increase the capacity, Ouyi invested about RMB10 million torebuild and modernize the manufacturing facilities. Now, all the facilities are GMP certified. Key equipment was imported from Europe. The annual capacity for finished drugs is 4.5 billion of tablets, 200 million of capsules, 300 million of ampoules of liquid injections, 300 million of sachets of granules.

       Ouyi has always been regarding product quality as our life . The QC department comprises 120 qualified and professional personnel and equipped with advanced precise analysis apparatus, such as Gas Chromatograph, High　Pressure Liquid Chromatograph, Ultraviolet Spectrophotometer and Atomic Spectrophotometer. The product quality can meet BP, USP, JP, EP and other requirements from customers.

      Ouyi has been awarded by Chinese Pharmaceutical Industry as “Outstanding Enterprise with excellent product quality” for 15 years.The products are very popular in domestic market and also exported to Europe, America, Africa, and Southeast Asia. We cooperate with IDA, Missionpharma, Holden, Pharmchem etc.